📰 Functional Outcomes News
Page 4 - Functional Outcomes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Functional Outcomes. Real-time updates on events, politics, business and more.
November 5, 2021
Antidepressants had a slight short-term effect on reducing the likelihood of depression diagnosis but there was no long-term improvement.
October 22, 2021
LXB improved all measures of function and work productivity among patients with idiopathic hypersomnia, according to findings presented at the American Neurological Association Annual Meeting.The treatment (calcium, magnesium, potassium and sodium oxybates; Jazz Pharmaceuticals Inc.), also referred to as lower-sodium oxybate (LXB) and Xywav, has the same active moiety at the same concentration as
August 19, 2021
Bacognize, a proprietary Bacopa monnieri extract, has a positive influence on a number of wellbeing aspects including mental wellbeing, alertness, focus, sleep, stress, according to a new study.
February 10, 2021
PARIS and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Biophytis (Euronext Growth Paris: ALBPS) (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, announces today that trading of its ordi...
December 17, 2020
Share: Accelerates revenue growth through Facilitates future global expansion via EOS established infrastructure Leverages the portfolio adoption driven by SafeOp with significant incremental opportunities to monetize clinical information Hosting webcast for investors December 17 at 6:00 A.M. PT CARLSBAD, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. ("ATEC" or the "Company") (NASDAQ:ATEC), a medical device company dedicated to revolutionizing the approach to spine surger...
December 16, 2020
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase ... Sio Gene TherapiesDecember 15, 2020 GMT - Generally well-tolerated with a favorable safety profile in five patients - Serum beta-galactosidase enzyme activity increased in all patients at all timepoints between Day 7 and Month 6, representing an approximate doubling in enzyme activity after gene trans...